Bengt Ljungberg

affiliated with the university
More filtering options
  1. 2016
  2. Reduced baseline sensitivity to Maraviroc inhibition among R5 HIV-1 isolates from individuals with severe immunodeficiency.

    Ulf Karlsson, Repits, J., Antonsson, L., Cederfjäll, E., Bengt Ljungberg, Ålenius, M., Sabirsh, A., Gisslen, M., Joakim Esbjörnsson & Marianne Jansson, 2016, In : Journal of Acquired Immune Deficiency Syndromes. 71, 3

    Research output: Contribution to journalLetter

  3. 2014
  4. 2013
  5. 2012
  6. Treatment of haemophilia A and B and von Willebrand's disease: summary and conclusions of a systematic review as part of a Swedish health-technology assessment.

    Erik Berntorp, Jan Astermark, Baghaei, F., Bergqvist, D., Holmström, M., Bengt Ljungberg, Norlund, A., Palmblad, J., Petrini, A., Stigendal, L. & Säwe, J., 2012, In : Haemophilia. 18, 2, p. 158-165

    Research output: Contribution to journalArticle

  7. 2011
  8. 2010
  9. COPD and the risk of tuberculosis--a population-based cohort study.

    Malin Inghammar, Ekbom, A., Gunnar Engström, Bengt Ljungberg, Romanus, V., Claes-Göran Löfdahl & Arne Egesten, 2010, In : PLoS ONE. 5, 4, e10138.

    Research output: Contribution to journalArticle

  10. 2009
  11. Mode of Coreceptor Use by R5 HIV Type 1 Correlates with Disease Stage: A Study of Paired Plasma and Cerebrospinal Fluid Isolates.

    Ulf Karlsson, Antonsson, L., Repits, J., Patrik Medstrand, Owman, C., Kidd-Ljunggren, K., Hagberg, L., Svennerholm, B., Marianne Jansson, Gisslén, M. & Bengt Ljungberg, 2009, In : AIDS Research and Human Retroviruses. 25, 12, p. 1297-1305

    Research output: Contribution to journalArticle

  12. 2008
  13. Medication report reduces number of medication errors when elderly patients are discharged from hospital

    Patrik Midlöv, Holmdahl, L., Eriksson, T., Bergkvist, A., Bengt Ljungberg, Håkan Widner, Nerbrand, C. & Höglund, P., 2008, In : PHARMACY WORLD & SCIENCE. 30, 1, p. 92-98

    Research output: Contribution to journalArticle

  14. 2005
  15. Pro- and anti-inflammatory substances modulate expression of the leukotriene B4 receptor, BLT1, in human monocytes.

    Pettersson, A., Sabirsh, A., Bristulf, J., Kidd-Ljunggren, K., Bengt Ljungberg, Owman, C. & Ulf Karlsson, 2005, In : Journal of Leukocyte Biology. 77, 6, p. 1018-1025

    Research output: Contribution to journalArticle

Previous 1 2 Next